Overview
Overview

Executive Committee

Supervisory Board Locations
Overview Satraplatin Kinase Inhibitors
Stock Major Shareholdings Key Figures Financial Reports SEC Filings Corporate Governance Analyst Coverage Shareholder´s Meeting Webcasts Information Request
Press Releases Contact Information
Working for GPC Biotech Germany USA

More Info

Print preview

Print

About the Company


Executive Committee

Torsten Hombeck, Ph.D.

Senior Vice President & Chief Financial Officer

 

Colin Freund
Senior Vice President, Business Development & Corporate Planning

 

Gregory H. Hamm
Senior Vice President, Human Resources & Corporate Integration

 

Brent Hatzis-Schoch
Senior Vice President and General Counsel

 

 

Biographies

 

 

Torsten Hombeck, Ph.D.

Senior Vice President & Chief Financial Officer 

 

Torsten Hombeck, Ph.D., has served as the Company’s Chief Financial Officer since January 2008.  He previously was GPC Biotech’s Vice President, Finance.  Dr. Hombeck joined the Company in 1999. Prior to joining GPC Biotech, he held positions in corporate finance and controlling, including financial oversight responsibility for South America, at Beiersdorf AG, an international branded consumer products company. Dr. Hombeck holds a Ph. D. in Finance and a Masters degree in business administration from the European Business School in Oestrich-Winkel, Germany. Dr. Hombeck also serves as a board member of Flakeboard America Ltd., a North American producer of composite wood products.

 

 

  

Colin Freund
Senior Vice President, Business Development & Corporate Planning

 

Prior to joining GPC Biotech in 2002, he held the position of Vice President Business Development at Double Twist, Inc., Oakland, CA, where he was responsible for creating alliances with a variety of genomics and proteomics companies. Prior to joining Double Twist, Mr. Freund was a project manager at the Boston Consulting Group, San Francisco, CA, and London, UK, where he managed assignments in the healthcare and high technology practice areas. Mr. Freund received his BA in Economics and Management Studies from the University of Cambridge, UK, and his MBA from Stanford University, CA.

 

 

 

Gregory H. Hamm
Senior Vice President, Human Resources & Corporate Integration

 

Gregory H. Hamm joined GPC Biotech in 1999 as Vice President, Bioinformatics and Information Technology, as well as Site Head of the Princeton facility. In 2001, Mr. Hamm was also appointed Vice President, Corporate Integration, which includes responsibility for Human Resources worldwide. In 2007, Mr. Hamm assumed his present role as Senior Vice President, Human Resources & Corporate Integration, with continued responsibility for Information Technology and the Princeton site.  Mr. Hamm was previously Vice President, Bioinformatics, at Genome Therapeutics Corporation (now Oscient Pharmaceuticals Corporation). Before 1995, Mr. Hamm was Director of the Molecular Biology Computing Laboratory at Rutgers University (U.S.). Earlier he was the founder of the EMBL Data Library and Head of Computing at the European Molecular Biology Laboratory (EMBL) in Heidelberg (Germany).

 

 

 

Brent Hatzis-Schoch
Senior Vice President and General Counsel

 

Brent Hatzis-Schoch joined GPC Biotech in 2003. Prior to joining GPC Biotech, Mr. Hatzis-Schoch was Associate General Counsel for Global Research & Development at Pharmacia Corporation, where he earlier held various senior legal positions in the transactional and international areas. Previously, he had been European legal counsel to Baxter Healthcare, based in Brussels, Belgium. He also spent several years in private practice in the United States and Germany. Mr. Hatzis-Schoch received his law degree from George Washington University, Washington D.C.

 

About the Company | Executive Committee